Lipoprotein(a)-hyperlipoproteinemia as cause of chronic spinal cord ischemia resulting in progressive myelopathy – successful treatment with lipoprotein apheresis

High concentrations of lipoprotein(a) (Lp(a)) represent an important independent and causal risk factor associated with adverse outcome in atherosclerotic cardiovascular disease (CVD). Effective Lp(a) lowering drug treatment is not available. Lipoprotein apheresis (LA) has been proven to prevent car...

Descripción completa

Detalles Bibliográficos
Autores principales: Heigl, Franz, Hettich, Reinhard, Mauch, Erich, Klingel, Reinhard, Fassbender, Cordula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352773/
https://www.ncbi.nlm.nih.gov/pubmed/28160245
http://dx.doi.org/10.1007/s11789-017-0081-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352773/
https://www.ncbi.nlm.nih.gov/pubmed/28160245
http://dx.doi.org/10.1007/s11789-017-0081-4

Ejemplares similares